Quantum Biopharma (QNTM) Depreciation & Amortization (CF) (2019 - 2026)
Quantum Biopharma (QNTM) reported Depreciation & Amortization (CF) of $127436.0 for Q1 2026, down 1.74% on a YoY basis from $129690.0 in Q1 2025, and down 12.32% sequentially from $145336.0 in Q3 2025.
Quantum Biopharma (QNTM) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $127436.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 41.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.20 Mn |
| 10 | Quantum Biopharma | 13.00 Bn | 13.00 Bn | - | 127,436.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 127,436.00 |
| Mar 31, 2026 | 127,436.00 |
| Sep 30, 2025 | 145,336.00 |
| Sep 30, 2025 | 145,336.00 |
| Jun 30, 2025 | 141,383.00 |
| Jun 30, 2025 | 141,383.00 |
| Mar 31, 2025 | 129,690.00 |
| Mar 31, 2025 | 129,690.00 |
| Sep 30, 2024 | 120,814.00 |
| Sep 30, 2024 | 120,814.00 |
| Jun 30, 2024 | 136,813.00 |
| Jun 30, 2024 | 136,813.00 |
| Mar 31, 2024 | 120,141.00 |
| Mar 31, 2024 | 120,141.00 |
| Sep 30, 2023 | 146,810.00 |
| Sep 30, 2023 | 146,810.00 |
| Jun 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | 1.13 Mn |
| Mar 31, 2023 | 1.13 Mn |